Clinical Trial Update: Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel

View source ↗

Summary

Clinical trial update notes ongoing recruitment for an immune biomarker study in cisplatin-ineligible patients receiving chemoradiotherapy with docetaxel for sq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Squamous Cell Carcinoma
• Laryngeal Squamous Cell Carcinoma
• Oral Cavity Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Squamous Cell Carcinoma of Oropharynx, Squamous Cell Carcinoma of the Hypopharynx | Status: RECRUITING